We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
(+10%)
Cap. Flow
+$19.1M
Cap. Flow
% of AUM
1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXUV
Dimensional US Vector Equity ETF
DXUV
|
+$8.37M |
| 2 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$7.66M |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$6.75M |
| 4 |
DXIV
Dimensional International Vector Equity ETF
DXIV
|
+$4.35M |
| 5 |
Dimensional Emerging Markets Value ETF
DFEV
|
+$2.47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.11M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$2.02M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$1.88M |
| 4 |
CoreCivic
CXW
|
+$1.84M |
| 5 |
Apple
AAPL
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.06% |
| 2 | Financials | 7.05% |
| 3 | Industrials | 6.04% |
| 4 | Consumer Discretionary | 4.74% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
2576
HomeTrust Bancshares
HTB
$815M
| $1.75K | ﹤0.01% |
35
| – | – |
|
2577
Vail Resorts
MTN
$5.13B
| $1.71K | ﹤0.01% |
13
-38
| -75% | -$4.95K |
|
2578
Globant
GLOB
$1.32B
| $1.71K | ﹤0.01% |
59
+53
| +883% | +$2.12K |
|
|
SHOE
2579
Shoe Station Group
SHOE
$388M
| $1.68K | ﹤0.01% |
+113
| New | +$1.93K |
|
2580
Lindblad Expeditions
LIND
$1.77B
| $1.67K | ﹤0.01% |
59
| – | – |
|
2581
Ambev
ABEV
$47.7B
| $1.66K | ﹤0.01% |
+529
| New | +$1.65K |
|
2582
Vita Coco
COCO
$3.96B
| $1.65K | ﹤0.01% |
25
-51
| -67% | -$3.44K |
|
2583
Harmony Gold Mining
HMY
$9.68B
| $1.64K | ﹤0.01% |
+108
| New | +$1.79K |
|
2584
BridgeBio Pharma
BBIO
$16.2B
| $1.64K | ﹤0.01% |
22
+3
| +16% | +$210 |
|
2585
Xeris Biopharma Holdings
XERS
$1.45B
| $1.64K | ﹤0.01% |
207
+158
| +322% | +$1.01K |
|
2586
Quantum Computing Inc
QUBT
$1.77B
| $1.63K | ﹤0.01% |
168
-52
| -24% | -$506 |
|
2587
Delek US
DK
$3.97B
| $1.63K | ﹤0.01% |
32
| – | – |
|
2588
BNY Mellon Concentrated International ETF
BKCI
$131M
| $1.62K | ﹤0.01% |
30
| – | – |
|
2589
Amdocs
DOX
$5.4B
| $1.62K | ﹤0.01% |
32
-231
| -88% | -$14.2K |
|
2590
Frontier Group Holdings
ULCC
$1.26B
| $1.61K | ﹤0.01% |
+204
| New | +$1.05K |
|
2591
Ramaco Resources Class A
METC
$731M
| $1.57K | ﹤0.01% |
+119
| New | +$1.74K |
|
|
LTM
2592
LATAM Airlines Group S.A.
LTM
$14.3B
| $1.57K | ﹤0.01% |
27
+17
| +170% | +$874 |
|
2593
LG Display
LPL
$3.37B
| $1.54K | ﹤0.01% |
+397
| New | +$1.82K |
|
2594
Copel
ELPC
$8.72B
| $1.54K | ﹤0.01% |
132
+23
| +21% | +$281 |
|
2595
Crane NXT
CXT
$3B
| $1.53K | ﹤0.01% |
30
-113
| -79% | -$4.82K |
|
2596
Sibanye-Stillwater
SBSW
$5.97B
| $1.52K | ﹤0.01% |
179
+137
| +326% | +$1.6K |
|
2597
Manitowoc
MTW
$503M
| $1.51K | ﹤0.01% |
109
| – | – |
|
2598
Nurix Therapeutics
NRIX
$2.46B
| $1.48K | ﹤0.01% |
+61
| New | +$1.04K |
|
2599
LegalZoom.com
LZ
$1.21B
| $1.45K | ﹤0.01% |
237
-1,497
| -86% | -$9.18K |
|
2600
Univest Financial
UVSP
$1.23B
| $1.44K | ﹤0.01% |
33
| – | – |
|
Similar funds
FLAM
AIM
MTCM
CNC
NOSC
RIM
ACG
C
Versant Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.
- Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
- Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
- Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
- Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
- Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
- Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
- Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.